{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:26:53Z","timestamp":1761676013222},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s12015-013-9431-x","type":"journal-article","created":{"date-parts":[[2013,2,28]],"date-time":"2013-02-28T20:29:54Z","timestamp":1362083394000},"page":"373-383","source":"Crossref","is-referenced-by-count":8,"title":["From Bench to Bedside: Review of Gene and Cell-Based Therapies and the Slow Advancement into Phase 3 Clinical Trials, with a Focus on Aastrom\u2019s Ixmyelocel-T"],"prefix":"10.1007","volume":"9","author":[{"given":"Ronnda L.","family":"Bartel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Booth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caryn","family":"Cramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Ledford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Watling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Zeigler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,3,1]]},"reference":[{"key":"9431_CR1","unstructured":"FDA website accessed 03 October 2012: http:\/\/www.fda.gov\/BiologicsBloodVaccines\/CellularGeneTherapyProducts\/ApprovedProducts\/default.htm ."},{"key":"9431_CR2","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197108122850711","volume":"285","author":"J Folkman","year":"1971","unstructured":"Folkman, J. (1971). Tumor angiogenesis: therapeutic implications. The New England Journal of Medicine, 285, 1182\u20131186.","journal-title":"The New England Journal of Medicine"},{"key":"9431_CR3","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4049\/jimmunol.122.1.166","volume":"122","author":"H Dvorak","year":"1979","unstructured":"Dvorak, H., Orenstein, N., Carvallo, A., et al. (1979). Induction of a fibrin-gel investment: an early event in line 10 heptocarcinoma growth mediated by tumor-secreted products. Journal of Immunology, 122, 166\u2013174.","journal-title":"Journal of Immunology"},{"key":"9431_CR4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/292154a0","volume":"292","author":"MJ Evans","year":"1981","unstructured":"Evans, M. J., & Kaufman, M. H. (1981). Establishment in culture of pluripotential cells from mouse embryos. Nature, 292, 154\u2013156.","journal-title":"Nature"},{"key":"9431_CR5","doi-asserted-by":"crossref","first-page":"7634","DOI":"10.1073\/pnas.78.12.7634","volume":"78","author":"GR Martin","year":"1981","unstructured":"Martin, G. R. (1981). Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proceedings of the National Academy of Sciences, 78, 7634\u20137638.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"9431_CR6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1139\/y2012-007","volume":"90","author":"K Brunt","year":"2012","unstructured":"Brunt, K., Weisel, R., & Li, R.-K. (2012). Stem cells and regenerative medicine\u2014future perspectives. Canadian Journal of Physiology and Pharmacology, 90, 327\u2013335.","journal-title":"Canadian Journal of Physiology and Pharmacology"},{"issue":"Suppl 1","key":"9431_CR7","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2006.09.024","volume":"33","author":"L Norgren","year":"2007","unstructured":"Norgren, L., Hiatt, W. R., Dormandy, J. A., Nehler, M. R., Harris, K. A., Fowkes, F. G., et al. (2007). Inter-society consensus for the management of peripheral arterial disease (TASC II). European Journal of Vascular and Endovascular Surgery, 33(Suppl 1), S1\u2013S75.","journal-title":"European Journal of Vascular and Endovascular Surgery"},{"key":"9431_CR8","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jvs.2009.08.073","volume":"51","author":"V Varu","year":"2010","unstructured":"Varu, V., Hogg, M., & Kibbe, M. (2010). Critical limb ischemia. Journal of Vascular Surgery, 51, 230\u2013241.","journal-title":"Journal of Vascular Surgery"},{"key":"9431_CR9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1177\/1538574407311106","volume":"41","author":"I Pipinos","year":"2008","unstructured":"Pipinos, I., Judge, A., Selsby, J., et al. (2008). The myopathy of peripheral arterial occlusive disease: part 1. Functional and histomorphological changes and evidence for mitochondrial dysfunction. Vascular and Endovascular Surgery, 41, 481\u2013489.","journal-title":"Vascular and Endovascular Surgery"},{"issue":"2","key":"9431_CR10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/1538574408315995","volume":"42","author":"I Pipinos","year":"2008","unstructured":"Pipinos, I., Judge, A., Selsby, J., et al. (2008). The myopathy of peripheral arterial occlusive disease: part 2.Oxidative stress, neuropathy, and shift in muscle fiber type. Vascular and Endovascular Surgery, 42(2), 101\u2013112.","journal-title":"Vascular and Endovascular Surgery"},{"key":"9431_CR11","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0741-5214(98)70356-8","volume":"27","author":"AD Nicoloff","year":"1998","unstructured":"Nicoloff, A. D., Taylor, L. M., Jr., McLafferty, R. B., Moneta, G. L., & Porter, J. M. (1998). Patient recovery after infrainguinal bypass grafting for limb salvage. Journal of Vascular Surgery, 27, 256\u2013263.","journal-title":"Journal of Vascular Surgery"},{"key":"9431_CR12","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1067\/mva.2001.114209","volume":"33","author":"GS Treiman","year":"2001","unstructured":"Treiman, G. S., Copland, S., Yellin, A. E., et al. (2001). Wound infections involving infrainguinal autogenous vein grafts: a current evaluation of factors determining successful graft preservation. Journal of Vascular Surgery, 33, 948\u2013954.","journal-title":"Journal of Vascular Surgery"},{"issue":"1","key":"9431_CR13","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/BF02693806","volume":"15","author":"AS Tretinyak","year":"2001","unstructured":"Tretinyak, A. S., Lee, E. S., Kuskowski, M. M., Caldwell, M. P., & Santilli, S. M. (2001). Revascularization and quality of life for patients with limb-threatening ischemia. Annals of Vascular Surgery, 15(1), 84\u201388.","journal-title":"Annals of Vascular Surgery"},{"issue":"4","key":"9431_CR14","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jvs.2010.04.057","volume":"52","author":"RW Sprengers","year":"2010","unstructured":"Sprengers, R. W., Teraa, M., Moll, F. L., de Wit, G. A., van der Graaf, Y., Verhaar, M. C., et al. (2010). Quality of life in patients with no-option critical limb ischemia underlines the need for new effective treatment. Journal of Vascular Surgery, 52(4), 843\u2013849.","journal-title":"Journal of Vascular Surgery"},{"issue":"3","key":"9431_CR15","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1067\/mva.2003.142","volume":"37","author":"MR Nehler","year":"2003","unstructured":"Nehler, M. R., Hiatt, W. R., & Taylor, L. M. (2003). Is revascularization and limb salvage always the best treatment for critical limb ischemia? Journal of Vascular Surgery, 37(3), 704\u2013708.","journal-title":"Journal of Vascular Surgery"},{"key":"9431_CR16","unstructured":"http:\/\/seer.cancer.gov\/statfacts\/html\/prost.html (accessed 08 October 2012)."},{"key":"9431_CR17","unstructured":"http:\/\/seer.cancer.gov\/statfacts\/html\/breast.html (accessed 08 October 2012)."},{"key":"9431_CR18","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1161\/01.CIR.0000142671.06167.91","volume":"110","author":"P Kaul","year":"2004","unstructured":"Kaul, P., Armstrong, P. W., Chang, W. C., et al. (2004). Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I. Circulation, 110, 1754\u20131760.","journal-title":"Circulation"},{"key":"9431_CR19","unstructured":"http:\/\/seer.cancer.gov\/statfacts\/html\/colorect.html (accessed 08 October 2012)."},{"issue":"11","key":"9431_CR20","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1212\/WNL.57.11.2000","volume":"57","author":"A Hartmann","year":"2001","unstructured":"Hartmann, A., Rundek, T., Mast, H., et al. (2001). Mortality and causes of death after first ischemic stroke: the Northern Manhattan stroke study. Neurology, 57(11), 2000\u20132005.","journal-title":"Neurology"},{"issue":"11","key":"9431_CR21","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1161\/01.CIR.91.11.2687","volume":"91","author":"JM Isner","year":"1995","unstructured":"Isner, J. M., Walsh, K., Symes, J., et al. (1995). Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease. Circulation, 91(11), 2687\u20132692.","journal-title":"Circulation"},{"issue":"9024","key":"9431_CR22","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0140-6736(96)03361-2","volume":"348","author":"JM Isner","year":"1996","unstructured":"Isner, J. M., Pieczek, A., Schainfeld, R., et al. (1996). Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet, 348(9024), 370\u2013374.","journal-title":"Lancet"},{"key":"9431_CR23","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/1358863X12438270","volume":"17","author":"G Ouma","year":"2012","unstructured":"Ouma, G., Jonas, R., Haris, M., & Mohler, E. (2012). Targets and delivery methods for therapeutic angiogenesis in peripheral artery disease. Vascular Medicine, 17, 174\u2013192.","journal-title":"Vascular Medicine"},{"issue":"Suppl 3","key":"9431_CR24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000088479","volume":"69","author":"N Ferrara","year":"2005","unstructured":"Ferrara, N. (2005). VEGF as a therapeutic target in cancer. Oncology, 69(Suppl 3), 11\u201316.","journal-title":"Oncology"},{"key":"9431_CR25","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1113\/eph8702285","volume":"87","author":"O Hudlicka","year":"2002","unstructured":"Hudlicka, O., Milkiewicz, M., Cotter, M. A., & Brown, M. D. (2002). Hypoxia and expression of VEGF-A protein in relation to capillary growth in electrically stimulated rat and rabbit skeletal muscles. Experimental Physiology, 87, 373\u2013381.","journal-title":"Experimental Physiology"},{"key":"9431_CR26","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0065-2660(05)54014-8","volume":"54","author":"PB Shah","year":"2005","unstructured":"Shah, P. B., & Losordo, D. W. (2005). Non-viral vectors for gene therapy: clinical trials in cardiovascular disease. Advances in Genetics, 54, 339\u2013361.","journal-title":"Advances in Genetics"},{"key":"9431_CR27","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.yexcr.2005.11.012","volume":"312","author":"M Shibuya","year":"2006","unstructured":"Shibuya, M., & Claesson-Welsh, L. (2006). Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Experimental Cell Research, 312, 549\u2013560.","journal-title":"Experimental Cell Research"},{"key":"9431_CR28","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/jama.293.12.1509","volume":"293","author":"P Wijngaarden van","year":"2005","unstructured":"van Wijngaarden, P., Coster, D. J., & Williams, K. A. (2005). Inhibitors of ocular neovascularization: promises and potential problems. JAMA: The Journal of the American Medical Association, 293, 1509\u20131513.","journal-title":"JAMA: The Journal of the American Medical Association"},{"key":"9431_CR29","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature04483","volume":"438","author":"N Ferrara","year":"2005","unstructured":"Ferrara, N., & Kerbel, R. S. (2005). Angiogenesis as a therapeutic target. Nature, 438, 967\u2013974.","journal-title":"Nature"},{"key":"9431_CR30","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1586\/14779072.3.3.521","volume":"3","author":"GC Hughes","year":"2005","unstructured":"Hughes, G. C., & Annex, B. H. (2005). Angiogenic therapy for coronary artery and peripheral arterial disease. Expert Review of Cardiovascular Therapy, 3, 521\u2013535.","journal-title":"Expert Review of Cardiovascular Therapy"},{"key":"9431_CR31","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1161\/01.CIR.0000159345.00591.8F","volume":"111","author":"M Simons","year":"2005","unstructured":"Simons, M. (2005). Angiogenesis: where do we stand now? Circulation, 111, 1556\u20136.","journal-title":"Circulation"},{"key":"9431_CR32","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/mthe.2002.0638","volume":"6","author":"K M\u00e4kinen","year":"2002","unstructured":"M\u00e4kinen, K., Manninen, H., Hedman, M., et al. (2002). Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study. Molecular Therapy, 6, 127\u2013133.","journal-title":"Molecular Therapy"},{"key":"9431_CR33","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/01.CIR.0000093398.16124.29","volume":"108","author":"S Rajagopalan","year":"2003","unstructured":"Rajagopalan, S., Mohler, E. R., 3rd, Lederman, R. J., et al. (2003). Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation, 108, 1933\u20131938.","journal-title":"Circulation"},{"key":"9431_CR34","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1152\/jappl.1989.66.3.1436","volume":"66","author":"O Mathieu-Costello","year":"1989","unstructured":"Mathieu-Costello, O., Hoppeler, H., & Weibel, E. R. (1989). Capillary tortuosity in skeletal muscles of mammals depends on muscle contraction. Journal of Applied Physiology, 66, 1436\u20131442.","journal-title":"Journal of Applied Physiology"},{"key":"9431_CR35","doi-asserted-by":"crossref","first-page":"H1668","DOI":"10.1152\/ajpheart.00743.2002","volume":"284","author":"PG Lloyd","year":"2003","unstructured":"Lloyd, P. G., Prior, B. M., Yang, H. T., & Terjung, R. I. (2003). Angiogenic growth factor expression in rat skeletal muscle in response to exercise training. American Journal of Physiology-Heart and Circulatory Physiology, 284, H1668\u2013H1678.","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"key":"9431_CR36","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/mt.2008.33","volume":"16","author":"S Nikol","year":"2008","unstructured":"Nikol, S., Baumgartner, I., Van Belle, E., et al. (2008). Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia. Molecular Therapy, 16, 972\u2013978.","journal-title":"Molecular Therapy"},{"key":"9431_CR37","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(11)60394-2","volume":"377","author":"J Belch","year":"2011","unstructured":"Belch, J., Hiatt, W., Baumgartner, I., et al. (2011). Effect of fibroblast growth factor NV1FGF on amputation and death: a randomized placebo-controlled trial of gene therapy in critical limb ischaemia. Lancet, 377, 1929\u20131937.","journal-title":"Lancet"},{"key":"9431_CR38","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s10439-007-9303-0","volume":"35","author":"F Mac Gabhann","year":"2007","unstructured":"Mac Gabhann, F., Ji, J. W., & Popel, A. S. (2007). Multi-scale computational models of pro-angiogenic treatments in peripheral arterial disease. Annals of Biomedical Engineering, 35, 982\u2013994.","journal-title":"Annals of Biomedical Engineering"},{"key":"9431_CR39","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1152\/japplphysiol.00800.2006","volume":"102","author":"F Mac Gabhann","year":"2007","unstructured":"Mac Gabhann, F., Ji, J. W., & Popel, A. S. (2007). VEGF gradients, receptor activation, and sprout guidance in resting and exercising skeletal muscle. Journal of Applied Physiology, 102, 722\u2013734.","journal-title":"Journal of Applied Physiology"},{"key":"9431_CR40","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1507\/endocrj.49.273","volume":"49","author":"R Morishita","year":"2002","unstructured":"Morishita, R., Aoki, M., Yo, Y., & Ogihara, T. (2002). Hepatocyte growth factor as cardiovascular hormone: role of HGF in the pathogenesis of cardiovascular disease. Endocrine Journal, 49, 273\u2013274.","journal-title":"Endocrine Journal"},{"key":"9431_CR41","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1161\/01.HYP.33.6.1379","volume":"33","author":"R Morishita","year":"1999","unstructured":"Morishita, R., Nakamura, S., Hayashi, S., et al. (1999). Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertension, 33, 1379\u20131384.","journal-title":"Hypertension"},{"key":"9431_CR42","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s004410100443","volume":"306","author":"AJ Cowin","year":"2001","unstructured":"Cowin, A. J., Kallincos, N., Hatzirodos, N., et al. (2001). Hepatocyte growth factor and macrophage-stimulating protein are upregulated during excisional wound repair in rats. Cell and Tissue Research, 306, 239\u2013250.","journal-title":"Cell and Tissue Research"},{"issue":"6","key":"9431_CR43","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.jvs.2010.07.044","volume":"52","author":"RJ Powell","year":"2010","unstructured":"Powell, R. J., Goodney, P., Mendelsohn, F. O., Moen, E. K., & Annex, B. H. (2010). HGF-0205 Trial Investigators. Safety and efficacy of patient specific intramuscular injection of HGF plasmid gene therapy on limb perfusion and wound healing in patients with ischemic lower extremity ulceration: results of the HGF-0205 trial. Journal of Vascular Surgery, 52(6), 1525\u20131530.","journal-title":"Journal of Vascular Surgery"},{"issue":"1","key":"9431_CR44","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1161\/CIRCULATIONAHA.107.727347","volume":"118","author":"RJ Powell","year":"2008","unstructured":"Powell, R. J., Simons, M., Mendelsohn, F. O., et al. (2008). Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia. Circulation, 118(1), 58\u201365.","journal-title":"Circulation"},{"issue":"1","key":"9431_CR45","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jvs.2012.03.255","volume":"56","author":"RJ Powell","year":"2012","unstructured":"Powell, R. J. (2012). Update on clinical trials evaluating the effect of biologic therapy in patients with critical limb ischemia. Journal of Vascular Surgery, 56(1), 264\u2013266.","journal-title":"Journal of Vascular Surgery"},{"key":"9431_CR46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0092-8674(00)80176-2","volume":"89","author":"K Guillemin","year":"1997","unstructured":"Guillemin, K., & Krasnow, M. A. (1997). The hypoxic response: huffing and HIFing. Cell, 89, 9\u201312.","journal-title":"Cell"},{"key":"9431_CR47","first-page":"609","volume":"378","author":"RH Wenger","year":"1997","unstructured":"Wenger, R. H., & Gassmann, M. (1997). Oxygen(es) and the hypoxia-inducible factor-1. Biological Chemistry, 378, 609\u2013616.","journal-title":"Biological Chemistry"},{"key":"9431_CR48","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","volume":"92","author":"GL Wang","year":"1995","unstructured":"Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995). Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proceedings of the National Academy of Sciences, 92, 5510\u20135514.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"9431_CR49","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1126\/science.1068592","volume":"295","author":"D Lando","year":"2002","unstructured":"Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J., & Whitelaw, M. L. (2002). Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science, 295, 858\u2013861.","journal-title":"Science"},{"key":"9431_CR50","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1161\/CIRCULATIONAHA.107.715847","volume":"116","author":"EI Chang","year":"2007","unstructured":"Chang, E. I., Loh, S. A., Ceradini, D. J., et al. (2007). Age decreases endothelial progenitor cell recruitment through decreases in hypoxia-inducible factor 1alpha stabilization during ischemia. Circulation, 116, 2818\u20132829.","journal-title":"Circulation"},{"key":"9431_CR51","doi-asserted-by":"crossref","first-page":"20399","DOI":"10.1073\/pnas.0911921106","volume":"106","author":"S Rey","year":"2009","unstructured":"Rey, S., Lee, K., Wang, C. J., et al. (2009). Synergistic effect of HIF-1alpha gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia. Proceedings of the National Academy of Sciences, 106, 20399\u201320404.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"9431_CR52","doi-asserted-by":"crossref","first-page":"32253","DOI":"10.1074\/jbc.271.50.32253","volume":"271","author":"LE Huang","year":"1996","unstructured":"Huang, L. E., Arany, Z., Livingston, D. M., & Bunn, H. F. (1996). Activation of hypoxiainducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. Journal of Biological Chemistry, 271, 32253\u201332259.","journal-title":"Journal of Biological Chemistry"},{"key":"9431_CR53","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1172\/JCI200318181","volume":"111","author":"M Safran","year":"2003","unstructured":"Safran, M., & Kaelin, W. G., Jr. (2003). HIF hydroxylation and the mammalian oxygensensing pathway. The Journal of Clinical Investigation, 111, 779\u2013783.","journal-title":"The Journal of Clinical Investigation"},{"key":"9431_CR54","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm0603-677","volume":"9","author":"CW Pugh","year":"2003","unstructured":"Pugh, C. W., & Ratcliffe, P. J. (2003). Regulation of angiogenesis by hypoxia: role of the HIF system. Nature Medicine, 9, 677\u2013684.","journal-title":"Nature Medicine"},{"key":"9431_CR55","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","volume":"30","author":"WG Kaelin Jr","year":"2008","unstructured":"Kaelin, W. G., Jr., & Ratcliffe, P. J. (2008). Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Molecular Cell, 30, 393\u2013402.","journal-title":"Molecular Cell"},{"key":"9431_CR56","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1161\/01.CIR.102.18.2255","volume":"102","author":"KA Vincent","year":"2000","unstructured":"Vincent, K. A., Shyu, K. G., Luo, Y., et al. (2000). Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF- 1alpha\/VP16 hybrid transcription factor. Circulation, 102, 2255\u20132261.","journal-title":"Circulation"},{"key":"9431_CR57","doi-asserted-by":"crossref","first-page":"18769","DOI":"10.1073\/pnas.0910561106","volume":"106","author":"K Sarkar","year":"2009","unstructured":"Sarkar, K., Fox-Talbot, K., Steenbergen, C., Bosch-Marce, M., & Semenza, G. L. (2009). Adenoviral transfer of HIF-1alpha enhances vascular responses to critical limb ischemia in diabetic mice. Proceedings of the National Academy of Sciences, 106, 18769\u201318774.","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"20","key":"9431_CR58","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1161\/01.CIR.0000128213.96779.61","volume":"109","author":"K Hiasa","year":"2004","unstructured":"Hiasa, K., Ishibashi, M., Ohtani, K., et al. (2004). Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor\/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization. Circulation, 109(20), 2454\u20132461.","journal-title":"Circulation"},{"issue":"5","key":"9431_CR59","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s12265-010-9207-5","volume":"3","author":"VF Segers","year":"2010","unstructured":"Segers, V. F., & Lee, R. T. (2010). Protein therapeutics for cardiac regeneration after myocardial infarction. Journal of Cardiovascular Translational Research, 3(5), 469\u2013477.","journal-title":"Journal of Cardiovascular Translational Research"},{"issue":"12","key":"9431_CR60","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1161\/CIRCULATIONAHA.110.991786","volume":"123","author":"VF Segers","year":"2011","unstructured":"Segers, V. F., Revin, V., Wu, W., et al. (2011). Protease-resistant stromal cell-derived factor-1 for the treatment of experimental peripheral artery disease. Circulation, 123(12), 1306\u20131315.","journal-title":"Circulation"},{"key":"9431_CR61","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1172\/JCI8296","volume":"105","author":"T Murohara","year":"2000","unstructured":"Murohara, T., Ikeda, H., Duan, J., et al. (2000). Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. The Journal of Clinical Investigation, 105, 1527\u20131536.","journal-title":"The Journal of Clinical Investigation"},{"key":"9431_CR62","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/01.RES.87.9.728","volume":"87","author":"JR Crosby","year":"2000","unstructured":"Crosby, J. R., Kaminski, W. E., Schatteman, G., et al. (2000). Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circulation Research, 87, 728\u2013730.","journal-title":"Circulation Research"},{"key":"9431_CR63","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/01.RES.85.3.221","volume":"85","author":"T Asahara","year":"1999","unstructured":"Asahara, T., Masuda, H., Takahashi, T., et al. (1999). Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circulation Research, 85, 221\u2013228.","journal-title":"Circulation Research"},{"key":"9431_CR64","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1097\/01.prs.0000201459.91559.7f","volume":"117","author":"JM Capla","year":"2006","unstructured":"Capla, J. M., Ceradini, D. J., Tepper, O. M., et al. (2006). Skin graft vascularization involves precisely regulated regression and replacement of endothelial cells through both angiogenesis and vasculogenesis. Plastic and Reconstructive Surgery, 117, 836\u2013844.","journal-title":"Plastic and Reconstructive Surgery"},{"key":"9431_CR65","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1182\/blood.V92.2.362","volume":"92","author":"Q Shi","year":"1998","unstructured":"Shi, Q., Rafii, S., Wu, M. H., et al. (1998). Evidence for circulating bone marrow-derived endothelial cells. Blood, 92, 362\u2013367.","journal-title":"Blood"},{"key":"9431_CR66","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/8462","volume":"5","author":"T Takahashi","year":"1999","unstructured":"Takahashi, T., Kalka, C., Masuda, H., et al. (1999). Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nature Medicine, 5, 434\u2013438.","journal-title":"Nature Medicine"},{"key":"9431_CR67","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/01.CIR.103.6.897","volume":"103","author":"S Shintani","year":"2001","unstructured":"Shintani, S., Murohara, T., Ikeda, H., et al. (2001). Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation, 103, 897\u2013903.","journal-title":"Circulation"},{"issue":"7","key":"9431_CR68","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1073\/pnas.97.7.3422","volume":"97","author":"C Kalka","year":"2000","unstructured":"Kalka, C., Masuda, H., Takahashi, T., et al. (2000). Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proceedings of the National Academy of Sciences, 97(7), 3422\u20133427.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"9431_CR69","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/SLA.0b013e318153fdcb","volume":"247","author":"RW Sprengers","year":"2008","unstructured":"Sprengers, R. W., Lips, D. J., Moll, F. L., & Verhaar, M. C. (2008). Progenitor cell therapy in patients with critical limb ischemia without surgical options. Annals of Surgery, 247, 411\u2013420.","journal-title":"Annals of Surgery"},{"key":"9431_CR70","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1160\/TH09-10-0688","volume":"103","author":"H Lawall","year":"2010","unstructured":"Lawall, H., Bramlage, P., & Amann, B. (2010). Stem cell and progenitor cell therapy in peripheral artery disease. Thrombosis and Haemostasis, 103, 696\u2013709.","journal-title":"Thrombosis and Haemostasis"},{"key":"9431_CR71","first-page":"393","volume":"3","author":"AJ Friedenstein","year":"1970","unstructured":"Friedenstein, A. J., Chailakhjan, R. K., & Lalykina, K. S. (1970). The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell and Tissue Kinetics, 3, 393\u2013403.","journal-title":"Cell and Tissue Kinetics"},{"key":"9431_CR72","first-page":"237","volume":"13","author":"AH Piersma","year":"1985","unstructured":"Piersma, A. H., Brockbank, K. G., Ploemacher, R. E., van Vliet, E., Brakel-van Peer, K. M., & Visser, P. J. (1985). Characterization of fibroblastic stromal cells from murine bone marrow. Experimental Hematology, 13, 237\u2013243.","journal-title":"Experimental Hematology"},{"key":"9431_CR73","first-page":"307","volume":"217B","author":"AI Caplan","year":"1986","unstructured":"Caplan, A. I. (1986). Molecular and cellular differentiation of muscle, cartilage, and bone in the developing limb. Progress in Clinical and Biological Research, 217B, 307\u2013318.","journal-title":"Progress in Clinical and Biological Research"},{"key":"9431_CR74","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger, M. F., Mackay, A. M., Beck, S. C., et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science, 284, 143\u2013147.","journal-title":"Science"},{"key":"9431_CR75","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1634\/stemcells.2005-0319","volume":"24","author":"M Honczarenko","year":"2006","unstructured":"Honczarenko, M., Le, Y., Swierkowski, M., Ghiran, I., Glodek, A. M., & Silberstein, L. E. (2006). Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells, 24, 1030\u20131041.","journal-title":"Stem Cells"},{"key":"9431_CR76","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1634\/stemcells.22-3-415","volume":"22","author":"JF Ji","year":"2004","unstructured":"Ji, J. F., He, B. P., Dheen, S. T., & Tay, S. S. (2004). Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells, 22, 415\u2013427.","journal-title":"Stem Cells"},{"key":"9431_CR77","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1634\/stemcells.2007-0054","volume":"25","author":"AL Ponte","year":"2007","unstructured":"Ponte, A. L., Marais, E., Gallay, N., et al. (2007). The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells, 25, 1737\u20131745.","journal-title":"Stem Cells"},{"key":"9431_CR78","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/jcb.21172","volume":"101","author":"J Ringe","year":"2007","unstructured":"Ringe, J., Strassburg, S., Neumann, K., et al. (2007). Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2. Journal of Cellular Biochemistry, 101, 135\u2013146.","journal-title":"Journal of Cellular Biochemistry"},{"key":"9431_CR79","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood-2004-09-3507","volume":"106","author":"V Sordi","year":"2005","unstructured":"Sordi, V., Malosio, M. L., Marchesi, F., et al. (2005). Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood, 106, 419\u2013427.","journal-title":"Blood"},{"issue":"6","key":"9431_CR80","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/ar130","volume":"2","author":"NJ Zvaifler","year":"2000","unstructured":"Zvaifler, N. J., Marinova-Mutafchieva, L., Adams, G., et al. (2000). Mesenchymal precursor cells in the blood of normal individuals. Arthritis Research, 2(6), 477\u2013488.","journal-title":"Arthritis Research"},{"key":"9431_CR81","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1365-2141.2000.01986.x","volume":"109","author":"A Erices","year":"2000","unstructured":"Erices, A., Conget, P., & Minguell, J. J. (2000). Mesenchymal progenitor cells in human umbilical cord blood. British Journal of Haematology, 109, 235\u2013242.","journal-title":"British Journal of Haematology"},{"issue":"12","key":"9431_CR82","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1091\/mbc.E02-02-0105","volume":"13","author":"PA Zuk","year":"2002","unstructured":"Zuk, P. A., Zhu, M., Ashjian, P., et al. (2002). Human adipose tissue is a source of multipotent stem cells. Molecular Biology of the Cell, 13(12), 4279\u20134295.","journal-title":"Molecular Biology of the Cell"},{"key":"9431_CR83","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P","volume":"44","author":"C Bari De","year":"2001","unstructured":"De Bari, C., Dell\u2019Accio, F., Tylzanowski, P., & Luyten, F. P. (2001). Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis and Rheumatism, 44, 1928\u20131942.","journal-title":"Arthritis and Rheumatism"},{"issue":"6","key":"9431_CR84","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1089\/scd.2007.0154","volume":"17","author":"S Barlow","year":"2008","unstructured":"Barlow, S., Brooke, G., Chatterjee, K., et al. (2008). Comparison of human placenta-and bone marrow-derived multipotent mesenchymal stem cells. Stem Cells and Development, 17(6), 1095\u20131107.","journal-title":"Stem Cells and Development"},{"key":"9431_CR85","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1634\/stemcells.2006-0709","volume":"25","author":"D Baksh","year":"2007","unstructured":"Baksh, D., Yao, R., & Tuan, R. S. (2007). Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells, 25, 1384\u20131392.","journal-title":"Stem Cells"},{"issue":"4","key":"9431_CR86","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.avsg.2008.02.017","volume":"22","author":"V Weel van","year":"2008","unstructured":"van Weel, V., van Tongeren, R. B., van Hinsbergh, V. W., van Bockel, J. H., & Quax, P. H. (2008). Vascular growth in ischemic limbs: a review of mechanisms and possible therapeutic stimulation. Annals of Vascular Surgery, 22(4), 582\u2013597.","journal-title":"Annals of Vascular Surgery"},{"issue":"Suppl A","key":"9431_CR87","doi-asserted-by":"crossref","first-page":"A48","DOI":"10.1016\/j.jvs.2007.02.030","volume":"45","author":"PK Shireman","year":"2007","unstructured":"Shireman, P. K. (2007). The chemokine system in arteriogenesis and hind limb ischemia. Journal of Vascular Surgery, 45(Suppl A), A48\u2013A56.","journal-title":"Journal of Vascular Surgery"},{"key":"9431_CR88","unstructured":"Goltry, K, Hampson, B, Venturi, N, Bartel, R. (2009). Large-scale production of adult stem cells for clinical use. In: Lakshmipathy, U, Chesnut, J. D., Thyagarajan, B., (editors). Emerging technology platforms for stem cells. John Wiley & Sons, Inc. p 153\u201368."},{"issue":"4","key":"9431_CR89","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/scrt117","volume":"3","author":"RL Bartel","year":"2012","unstructured":"Bartel, R. L., Cramer, C., Ledford, K., et al. (2012). The Aastrom experience. Stem Cell Research & Therapy, 3(4), 26.","journal-title":"Stem Cell Research & Therapy"},{"key":"9431_CR90","doi-asserted-by":"crossref","unstructured":"Ledford, K. J., Murphy, E. N., Zeigler, F., Bartel, R. L. (2012). Evidence for the beneficial effects of ixmyelocel-T in the treatment of critical limb ischemia. Arteriosclerosis, Thrombosis, and Vascular Biology. April.","DOI":"10.1161\/atvb.32.suppl_1.A280"},{"issue":"6","key":"9431_CR91","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/mt.2012.52","volume":"20","author":"RJ Powell","year":"2012","unstructured":"Powell, R. J., Marston, W. A., Berceli, S. A., et al. (2012). Cellular therapy with Ixmyelocel-T to treat critical limb ischemia: the randomized, double-blind, placebo-controlled RESTORE-CLI trial. Molecular Therapy, 20(6), 1280\u20131286.","journal-title":"Molecular Therapy"},{"key":"9431_CR92","unstructured":"http:\/\/circ.ahajournals.org\/cgi\/content\/meeting_abstract\/124\/21_MeetingAbstracts\/A8547?sid= ba1839f3-67aa-4e92-838e-e72a7da27a92 (accessed 08 October 2012)."},{"key":"9431_CR93","unstructured":"CLI Performance Goals Work Group web site. Available from: http:\/\/www.criticallimb.org\/ (accessed 08 October 2012)."},{"key":"9431_CR94","first-page":"315","volume":"108","author":"M Ruponen","year":"2005","unstructured":"Ruponen, M., Hyvonen, Z., Urtti, A., & Yia-Hertuala, S. (2005). Nonviral gene delivery methods in cardiovascular diseases. Methods in Molecular Medicine, 108, 315\u2013328.","journal-title":"Methods in Molecular Medicine"},{"issue":"3","key":"9431_CR95","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/00365516809076995","volume":"21","author":"B Pernow","year":"1968","unstructured":"Pernow, B., & Zetterquist, S. (1968). Metabolic evaluation of the leg blood flow in claudicating patients with arterial obstructions at different levels. Scandinavian Journal of Clinical & Laboratory Investigation, 21(3), 277\u2013287.","journal-title":"Scandinavian Journal of Clinical & Laboratory Investigation"},{"key":"9431_CR96","unstructured":"ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 [08 October 2012]. Available from: http:\/\/clinicaltrials.gov\/ct2\/results?term=critical+limb+ischemia&recr=Open&no_unk=Y&rslt=&type=&cond=&intr=stem+cells&outc=&spons=&lead=&id=&state1=&cntry1=&state2=&cntry2=&state3=&cntry3=&locn=&gndr=&phase=2&rcv_s=&rcv_e=&lup_s=&lup_e= ."},{"key":"9431_CR97","doi-asserted-by":"crossref","unstructured":"Benoit, E., O\u2019Donnell, T. F. Jr., Iafrati, M. D., et al. (2011). The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial design. Journal of Translational Medicine, 9, 165.","DOI":"10.1186\/1479-5876-9-165"},{"key":"9431_CR98","doi-asserted-by":"crossref","unstructured":"Kusumanto, Y. H., van Weel, V., Mulder, N. H., et al. (2006). Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial. Human Gene Therapy, 17(6), 683\u2013691.","DOI":"10.1089\/hum.2006.17.683"},{"key":"9431_CR99","doi-asserted-by":"crossref","unstructured":"Creager, M. A., Olin, J. W., Belch, J. J., et al. (2011). Effect of hypoxia-inducible factor-1alpha gene therapy on walking performance in patients with intermittent claudication. Circulation, 124(16), 1765\u20131773.","DOI":"10.1161\/CIRCULATIONAHA.110.009407"},{"key":"9431_CR100","doi-asserted-by":"crossref","unstructured":"Sprengers, R. W., Moll, F. L., Teraa, M., Verhaar, M. C., JUVENTAS Study Group. (2010). Rationale and design of the JUVENTAS trial for repeated intra-arterial infusion of autologous bone marrow-derived mononuclear cells in patients with critical limb ischemia. Journal of Vascular Surgery, 51(6), 1564\u20131568.","DOI":"10.1016\/j.jvs.2010.02.020"},{"key":"9431_CR101","unstructured":"Tateishi-Yuyama, E., Matsubara, H., Murohara, T., et al. (2002). Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet, 360(9331), 427\u2013435."},{"key":"9431_CR102","doi-asserted-by":"crossref","unstructured":"Walter, D. H., Krankenberg, H., Balzer, J. O., et al. (2011). Intra-arterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: a randomized-start, placebo-controlled pilot trial (PROVASA). Circulation: Cardiovascular Intervention, 4(1), 26\u201337.","DOI":"10.1161\/CIRCINTERVENTIONS.110.958348"},{"key":"9431_CR103","unstructured":"Losordo, D. (2010). Randomized double-blind, placebo controlled trial of autologous cd34+ cell therapy for critical limb ischemia: 1\u00a0year results. Circulation, 122, A16920."},{"key":"9431_CR104","doi-asserted-by":"crossref","unstructured":"Murphy, M. P., Lawson, J. H., Rapp, B. M., et al. (2011). Autologous bone marrow mononuclear cell therapy is safe and promotes amputation free survival in patients with critical limb ischemia. Journal of Vascular Surgery, 53(6), 1565\u20131574.","DOI":"10.1016\/j.jvs.2011.01.074"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-013-9431-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12015-013-9431-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-013-9431-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T20:32:16Z","timestamp":1688070736000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12015-013-9431-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,1]]},"references-count":104,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["9431"],"URL":"https:\/\/doi.org\/10.1007\/s12015-013-9431-x","relation":{},"ISSN":["1550-8943","1558-6804"],"issn-type":[{"value":"1550-8943","type":"print"},{"value":"1558-6804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,1]]}}}